Concepedia
Statistics
Publications
17
Citations
720
H-Index
15
Active since
2012
Affiliations
UCB Pharma (United Kingdom)(Current)
UCB Pharma (Belgium)
UCB Pharma (United States)
UCB Pharma (Germany)
The University of Melbourne
Simon Borghs is an author at UCB Pharma (United Kingdom) specializing in medicine, epilepsy, and pharmacology.
Publications per year
2012–2020
An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
Stephen L. Yates, Toufic Fakhoury, Wei Liang et al. · Epilepsy & Behavior · 2015 · 154 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +14
Defining minimally important change in QOLIE-31 scores: Estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures
Simon Borghs, Christine de la Loge, Joyce A. Cramer · Epilepsy & Behavior · 2012 · 92 citations
Medicine, Pharmacology, Pharmacotherapy +5
Safety, tolerability, and seizure control during long‐term treatment with adjunctive brivaracetam for partial‐onset seizures
Manuel Toledo, John Whitesides, Jimmy Schiemann et al. · Epilepsia · 2016 · 72 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures
Viktor Farkas, Barbara Steinborn, J. Robert Flamini et al. · Neurology · 2019 · 63 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +16
Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial
Wendy Waldman Zadeh, Antonio Escartín, William Byrnes et al. · Seizure · 2015 · 50 citations · Full text
1–5 of 17